Sicurella M, De Chiara M, Neri L
Cells. 2025; 14(4).
PMID: 39996741
PMC: 11853774.
DOI: 10.3390/cells14040269.
Albassam H, Almutairi O, Alnasser M, Altowairqi F, Almutairi F, Alobid S
J Enzyme Inhib Med Chem. 2025; 40(1):2468852.
PMID: 39992303
PMC: 11852364.
DOI: 10.1080/14756366.2025.2468852.
Zhang B, Leung P, Cho W, Wong C, Wang D
J Transl Med. 2025; 23(1):184.
PMID: 39953539
PMC: 11829425.
DOI: 10.1186/s12967-025-06144-8.
Hopkinson M, Pitsillides A
Int J Exp Pathol. 2025; 106(2):e12525.
PMID: 39923120
PMC: 11807010.
DOI: 10.1111/iep.12525.
Thomas N, Alharbi M, Muripiti V, Banothu J
Mol Divers. 2025; .
PMID: 39873887
DOI: 10.1007/s11030-024-11092-4.
Class III Phosphatidylinositol-3 Kinase/Vacuolar Protein Sorting 34 in Cardiovascular Health and Disease.
Shen Y, Gleghorn J
J Cardiovasc Transl Res. 2025; .
PMID: 39821606
DOI: 10.1007/s12265-024-10581-z.
New Emerging Therapies Targeting PI3K/AKT/mTOR/PTEN Pathway in Hormonal Receptor-Positive and HER2-Negative Breast Cancer-Current State and Molecular Pathology Perspective.
Liu L, Graff S, Wang Y
Cancers (Basel). 2025; 17(1.
PMID: 39796647
PMC: 11718791.
DOI: 10.3390/cancers17010016.
Structural modeling of phosphatidylinositol 3-kinase-γ with novel derivatives of stilbenoids.
Rathee S, Rajan M, Sharma S, Hariprasad G
Biochem Biophys Rep. 2024; 40:101861.
PMID: 39634338
PMC: 11616550.
DOI: 10.1016/j.bbrep.2024.101861.
The Importance of Phosphoinositide 3-Kinase in Neuroinflammation.
Wright B, King S, Suphioglu C
Int J Mol Sci. 2024; 25(21).
PMID: 39519189
PMC: 11546674.
DOI: 10.3390/ijms252111638.
Exploring the potential of myo-inositol in thyroid disease management: focus on thyroid cancer diagnosis and therapy.
Razavi S, Kalari M, Haghzad T, Haddadi F, Nasiri S, Hedayati M
Front Endocrinol (Lausanne). 2024; 15:1418956.
PMID: 39329107
PMC: 11424451.
DOI: 10.3389/fendo.2024.1418956.
Pik3c3 expression profiling in the mouse kidney and its role in proximal tubule cell physiology.
Liu T, Yuan J, Dai C, Chen M, Fan J, Humphreys B
Am J Physiol Cell Physiol. 2024; 327(4):C1094-C1110.
PMID: 39250817
PMC: 11481994.
DOI: 10.1152/ajpcell.00564.2023.
The multifaceted role of mitochondria in autism spectrum disorder.
Khaliulin I, Hamoudi W, Amal H
Mol Psychiatry. 2024; 30(2):629-650.
PMID: 39223276
PMC: 11753362.
DOI: 10.1038/s41380-024-02725-z.
Subunit-Specific Developmental Roles of PI3K in SF1-Expressing Cells.
Huynh M, Lyoo S, Yang D, Choi Y, Kim K
Endocrinol Metab (Seoul). 2024; 39(5):793-802.
PMID: 39212037
PMC: 11525698.
DOI: 10.3803/EnM.2024.1999.
Improved production of class I phosphatidylinositol 4,5-bisphosphate 3-kinase.
Messing S, Widmeyer S, Denson J, Mehalko J, Wall V, Drew M
Protein Expr Purif. 2024; 225:106582.
PMID: 39173964
PMC: 11421577.
DOI: 10.1016/j.pep.2024.106582.
The essential roles of lncRNAs/PI3K/AKT axis in gastrointestinal tumors.
Li P, Ma X, Gu X
Front Cell Dev Biol. 2024; 12:1442193.
PMID: 39161590
PMC: 11330846.
DOI: 10.3389/fcell.2024.1442193.
Repurposing Inhibitors of Phosphoinositide 3-kinase as Adjuvant Therapeutics for Bacterial Infections.
Fleeman R
Front Antibiot. 2024; 2.
PMID: 38983593
PMC: 11233138.
DOI: 10.3389/frabi.2023.1135485.
PI3K Inhibitors in Hematology: When One Door Closes….
Skanland S, Okkenhaug K, Davids M
Clin Cancer Res. 2024; 30(17):3667-3675.
PMID: 38967552
PMC: 11371526.
DOI: 10.1158/1078-0432.CCR-24-0967.
Resistance to Targeted Inhibitors of the PI3K/AKT/mTOR Pathway in Advanced Oestrogen-Receptor-Positive Breast Cancer.
Browne I, Okines A
Cancers (Basel). 2024; 16(12).
PMID: 38927964
PMC: 11201395.
DOI: 10.3390/cancers16122259.
Empagliflozin rescues lifespan and liver senescence in naturally aged mice.
Long J, Ren Z, Duan Y, Tao W, Li X, Li S
Geroscience. 2024; 46(5):4969-4986.
PMID: 38922380
PMC: 11336130.
DOI: 10.1007/s11357-024-01250-9.
Structural investigation of Trypanosoma cruzi Akt-like kinase as drug target against Chagas disease.
Stadler K, Ortiz-Joya L, Sahrawat A, Buhlheller C, Gruber K, Pavkov-Keller T
Sci Rep. 2024; 14(1):10039.
PMID: 38693166
PMC: 11063076.
DOI: 10.1038/s41598-024-59654-8.